Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 761 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
MINI REVIEW
Year : 2012  |  Volume : 16  |  Issue : 8  |  Page : 242-244

What the future holds for gliptins


Apollo Centre for Obesity Diabetes and Endocrinology, Indraprastha Apollo Hospital, Sarita Vihar, New Delhi, India

Correspondence Address:
Subhash K Wangnoo
Senior Consultant, Endocrinologist, Apollo Centre for Obesity Diabetes and Endocrinology, Indraprastha Apollo Hospital, Sarita Vihar, New Delhi
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2230-8210.104050

Rights and Permissions

Gliptins have revolutionised the treatment of Type 2 Diabetes Mellitus, addressing the hyperglycemia through its effects on the alpha and beta cells of the pancreas. In this article,we review the extra-glycemic effects of gliptins on central nervous system, cardiovascular biology and the bone health and concerns regarding pancreatitis and pancreatic cancer.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1511    
    Printed25    
    Emailed0    
    PDF Downloaded375    
    Comments [Add]    

Recommend this journal